Are TG/HDL, TyG, TyG-BMI, and ZJU indices associated with Metabolic Dysfunction-Associated Fatty Liver Disease in patients with Type 2 Diabetes?
TyG-BMI and TG/HDL indices may serve as useful non-invasive screening tools for identifying MAFLD in patients with type 2 diabetes.
TyG-BMI is a significant determinant for the diagnosis of MAFLD in T2DM patients, while TG/HDL is more effective for screening in female patients.
Yang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: